| Not Yet Recruiting | Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812 | Beth Israel Deaconess Medical Center | N/A |
| Recruiting | CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic C NCT07257419 | St. Jude Children's Research Hospital | Phase 1 |
| Not Yet Recruiting | Allergy Delabeling in Antibiotic Stewardship - Intervention NCT07133074 | Ebbing Lautenbach | N/A |
| Recruiting | Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients U NCT06856226 | National Cancer Institute (NCI) | — |
| Recruiting | Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT NCT07511127 | Ruijin Hospital | Phase 3 |
| Active Not Recruiting | Expressive Writing Program Among Young Adults With Blood Cancer NCT07413991 | Blood Cancer United | N/A |
| Enrolling By Invitation | Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials NCT07474051 | AvenCell Therapeutics, Inc. | — |
| Recruiting | ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biops NCT07203534 | Wake Forest University Health Sciences | N/A |
| Recruiting | Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy NCT06579469 | St. Jude Children's Research Hospital | — |
| Recruiting | Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During an NCT06532773 | Duke University | N/A |
| Recruiting | HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT NCT06731504 | Duke University | EARLY_Phase 1 |
| Recruiting | Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies NCT07189117 | University Hospital, Basel, Switzerland | — |
| Recruiting | TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve NCT07052370 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | HEME Home Transfusion Program NCT06487247 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies NCT07044544 | University of Alabama at Birmingham | Phase 1 |
| Recruiting | T-cell Developmental Status in Patients With Malignant Hematological Tumors NCT07035938 | The First Affiliated Hospital of Xiamen University | — |
| Recruiting | Home Blood Transfusions NCT07121140 | Thomas Jefferson University | N/A |
| Recruiting | Implementation of an Oral Chemotherapy Adherence Intervention NCT06989489 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Withdrawn | TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant NCT05968170 | Neena Kapoor, M.D. | N/A |
| Recruiting | A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant NCT07006506 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial NCT05820126 | Ottawa Hospital Research Institute | Phase 2 |
| Recruiting | Mosaic Trial for Stem Cell Transplant Recipients NCT06960993 | Northwestern University | N/A |
| Recruiting | Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers NCT07300735 | Alexandria University | N/A |
| Completed | Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort NCT07249138 | Children's Hospital of Fudan University | — |
| Not Yet Recruiting | A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem C NCT06792630 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Recruiting | BMT-CARE: Psychosocial Intervention for Transplant Caregivers NCT06472089 | Massachusetts General Hospital | N/A |
| Recruiting | CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors NCT06720324 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 / Phase 2 |
| Withdrawn | TCR Alpha/Beta and CD19-deplete Haplo-HSCT NCT05288595 | University of Colorado, Denver | Phase 2 |
| Recruiting | Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC NCT05066412 | University Hospital, Geneva | Phase 1 |
| Recruiting | Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy NCT06689800 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Ste NCT06676852 | Massachusetts General Hospital | N/A |
| Recruiting | Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High R NCT06541067 | Nantes University Hospital | Phase 2 |
| Recruiting | Early Assessment of Cardiac Function After Treatment With CAR-T Cells NCT06350994 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia NCT07014449 | Hangzhou Weben Pharma Co., Ltd | Phase 1 |
| Completed | Home Transfusion for HEME NCT05509439 | Dana-Farber Cancer Institute | N/A |
| Recruiting | CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies NCT06326463 | St. Jude Children's Research Hospital | Phase 1 |
| Completed | VitalTraq for the Detection of CRS NCT06415656 | Duke University | N/A |
| Recruiting | FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis NCT06566209 | Mayo Clinic | — |
| Not Yet Recruiting | Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm NCT06582186 | University Hospital, Grenoble | Phase 4 |
| Recruiting | Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral NCT06398457 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | EARLY_Phase 1 |
| Recruiting | An Extension Study for Patients Previously Enrolled in Studies With Pelabresib NCT06401356 | Novartis Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Maligna NCT06528249 | Zhejiang Provincial People's Hospital | Phase 1 |
| Recruiting | Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate NCT06252870 | Nantes University Hospital | Phase 2 |
| Recruiting | TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816 | Shenzhen TargetRx Co., Ltd. | Phase 1 |
| Active Not Recruiting | CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT NCT06449586 | Ruijin Hospital | Phase 3 |
| Recruiting | Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transpla NCT06462365 | Tr1X, Inc. | Phase 1 |
| Recruiting | Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment NCT06373471 | Odense University Hospital | N/A |
| Recruiting | TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies NCT06206174 | Shenzhen TargetRx Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen R NCT05887167 | Joshua Sasine, MD, PhD | Phase 1 |
| Not Yet Recruiting | Early Neutropenic Fever De-escalation of Antibiotics Study NCT06278896 | Brigham and Women's Hospital | Phase 3 |
| Recruiting | Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788 | Kura Oncology, Inc. | Phase 1 |
| Not Yet Recruiting | A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy NCT06211751 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Active Not Recruiting | A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors NCT06153797 | Brigham and Women's Hospital | N/A |
| Recruiting | αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) NCT06082947 | Nationwide Children's Hospital | N/A |
| Unknown | IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related NCT06130709 | University Hospital, Caen | — |
| Recruiting | Intervention for Fatigue in HCT Recipients NCT05715047 | Massachusetts General Hospital | N/A |
| Enrolling By Invitation | A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies NCT06208878 | CRISPR Therapeutics AG | — |
| Recruiting | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801 | Children's Hospital Medical Center, Cincinnati | — |
| Terminated | ATG Plus Low-dose PT-Cy for GVHD Prevention NCT06108739 | Peking University People's Hospital | Phase 3 |
| Terminated | Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving NCT06102213 | Prolacta Bioscience | Phase 2 |
| Unknown | A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML NCT05690425 | Biocity Biopharmaceutics Co., Ltd. | Phase 1 |
| Active Not Recruiting | Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant NCT05709912 | Massachusetts General Hospital | N/A |
| Recruiting | Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT NCT05921318 | Peking University People's Hospital | — |
| Completed | Evaluation of ClearLLab LS Screening Panel NCT05819762 | Beckman Coulter, Inc. | — |
| Unknown | Oral Complications in Hematological Malignancies NCT05758207 | Assiut University | — |
| Enrolling By Invitation | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenviron NCT05600933 | National Cancer Institute (NCI) | — |
| Recruiting | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Enrolling By Invitation | AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens) NCT05889806 | Audubon Bioscience | — |
| Recruiting | CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT NCT05943067 | University Hospital Tuebingen | Phase 1 / Phase 2 |
| Recruiting | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796 | Dana-Farber Cancer Institute | — |
| Recruiting | Telerehabilitation in Hemato-oncological Survivors NCT05779605 | Brno University Hospital | N/A |
| Terminated | A Phase I Study of BR108 in Hematological Malignancies NCT06018506 | BioRay Pharmaceutical Co., Ltd. | Phase 1 |
| Terminated | Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Mali NCT05579769 | St. Jude Children's Research Hospital | Phase 2 |
| Unknown | Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule NCT05716919 | Machaon Biotherapeutics, Inc. | Phase 1 |
| Recruiting | Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion NCT05807789 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Unknown | Early Detection and Screening of Hematological Malignancies - SANGUINE NCT05735704 | JaxBio Ltd | — |
| Recruiting | Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients NCT05529069 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignanc NCT05707325 | Westlake Therapeutics | EARLY_Phase 1 |
| Terminated | Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients W NCT04673175 | Weill Medical College of Cornell University | Phase 4 |
| Recruiting | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular T NCT05646576 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors NCT05683353 | Peking University First Hospital | — |
| Completed | Survivorship Post-HCT Optimization Program NCT05238376 | Duke University | N/A |
| Terminated | A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo NCT05284032 | Firas El Chaer, MD | EARLY_Phase 1 |
| Recruiting | Diet and Cognitive Training in Hematologic Cancer Survivors NCT05708716 | University of Alabama at Birmingham | N/A |
| Recruiting | A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy NCT05583734 | Aperture Medical Technology, LLC | N/A |
| Recruiting | Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies NCT05476770 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 1 |
| Unknown | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects NCT05610202 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Recruiting | Response to Influenza Vaccination in Pediatric Oncology Patients NCT05384288 | St. Jude Children's Research Hospital | — |
| Recruiting | Immune Profiling for Cancer Immunotherapy Response NCT06116032 | Dartmouth-Hitchcock Medical Center | — |
| Active Not Recruiting | Immunity to Infection in Healthy Participants and Participants With Cancer NCT05787964 | University Hospital Tuebingen | — |
| Suspended | Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbet NCT05400122 | David Wald | Phase 1 |
| Unknown | Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill NCT05443854 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Withdrawn | CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies NCT04282174 | Baptist Health South Florida | Phase 2 |
| Recruiting | Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation NCT05417971 | Northside Hospital, Inc. | — |
| Unknown | Central Venous Catheter-related Complications in Patients Under Anticancer Treatment NCT05455866 | Centre Hospitalier Alpes Leman | — |
| Recruiting | Global Cardio Oncology Registry NCT05598879 | The Cleveland Clinic | — |
| Completed | Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. NCT05042479 | Nantes University Hospital | N/A |
| Completed | Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipi NCT05164016 | St. Jude Children's Research Hospital | — |
| Unknown | Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome NCT05413356 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies NCT05397132 | Duke University | — |
| Unknown | The Association of Microbiota Composition With cGVHD After Allo-HSCT NCT05355675 | First Affiliated Hospital of Zhejiang University | — |
| Completed | Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemot NCT05270655 | Chinese University of Hong Kong | N/A |
| Withdrawn | Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malign NCT04684979 | Baptist Health South Florida | Phase 2 |
| Enrolling By Invitation | Long-Term Follow-up Study NCT05332054 | Caribou Biosciences, Inc. | — |
| Unknown | Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic St NCT05609227 | Baskent University | N/A |
| Completed | Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT NCT05216978 | Brigham and Women's Hospital | N/A |
| Unknown | Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation NCT05250362 | Sichuan University | Phase 1 / Phase 2 |
| Recruiting | Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Imm NCT04707300 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Recruiting | Solving Riddles Through Sequencing NCT05046444 | Munich Leukemia Laboratory | — |
| Unknown | Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis NCT05158608 | National Research Center for Hematology, Russia | Phase 3 |
| Completed | Positive Psychology Intervention In HSCT NCT05147311 | Brigham and Women's Hospital | N/A |
| Active Not Recruiting | Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective S NCT05396157 | Mount Sinai Hospital, Canada | — |
| Completed | Remote Temperature Data for Early Detection of Febrile Neutropenia NCT05180838 | University of Colorado, Denver | — |
| Unknown | Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT NCT05084027 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Completed | Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population NCT04889937 | Leuko Labs, Inc. | — |
| Withdrawn | MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation NCT03986086 | Nelson Chao | Phase 1 / Phase 2 |
| Completed | A Study of DT2216 in Relapsed/Refractory Malignancies NCT04886622 | Dialectic Therapeutics, Inc | Phase 1 |
| Completed | Lighting Intervention for Cancer-related Fatigue NCT04827446 | University of Michigan Rogel Cancer Center | N/A |
| Completed | Removing Transfusion Dependence as a Barrier to Hospice Enrollment NCT05063591 | Adam Olszewski | N/A |
| Completed | GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid NCT04944888 | Chinese PLA General Hospital | Phase 1 |
| Completed | IIT2020-20-SHIRAZIP-WALK: Nature Walks NCT04896580 | Cedars-Sinai Medical Center | N/A |
| Completed | Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies NCT04649112 | Precision BioSciences, Inc. | Phase 1 |
| Completed | VR for Symptom Control and Wellbeing NCT04821466 | Royal Cornwall Hospitals Trust | N/A |
| Completed | A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Ma NCT04795128 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
| Completed | Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology NCT04826458 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | N/A |
| Completed | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic NCT04847050 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients NCT04852796 | Centre Hospitalier de Cornouaille | — |
| Completed | Mindfulness and CBT for Sleep NCT04736056 | Duke University | N/A |
| Completed | Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy NCT05009719 | St. Petersburg State Pavlov Medical University | Phase 1 / Phase 2 |
| Completed | Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Com NCT04952766 | Centre Hospitalier Régional d'Orléans | Phase 4 |
| Unknown | Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients NCT04809181 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Completed | Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignanci NCT04710212 | Duke University | — |
| Terminated | Thrombosomes® in Bleeding Thrombocytopenic Patients Study NCT04631211 | Cellphire Therapeutics, Inc. | Phase 2 |
| Recruiting | Prospective Validation of the OHI Index NCT05882175 | Meir Medical Center | — |
| Completed | Hospital at Home at EOL in Heme Malignancies NCT04690205 | Massachusetts General Hospital | N/A |
| Completed | Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care NCT04757545 | Rigshospitalet, Denmark | N/A |
| Completed | Effects of NMES and Exercise in Hematological Cancer NCT04755465 | Acibadem University | N/A |
| Unknown | COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies NCT04776005 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | Radiation Post-CAR T in Refractory Lymphoma NCT04473937 | Massachusetts General Hospital | N/A |
| Unknown | B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation NCT04682314 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application NCT04496375 | Institut Paoli-Calmettes | — |
| Active Not Recruiting | Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation NCT04395222 | Weill Medical College of Cornell University | Phase 2 |
| Unknown | Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) NCT04720144 | Centre Hospitalier Universitaire Vaudois | — |
| Completed | A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT NCT04509765 | NYU Langone Health | N/A |
| Active Not Recruiting | Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies NCT04552288 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Withdrawn | Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematologi NCT04392128 | Institut de cancérologie Strasbourg Europe | Phase 2 |
| Completed | Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice NCT04454723 | University of Oklahoma | N/A |
| Completed | Besponsa Post Marketing Surveillance Study NCT04307134 | Pfizer | — |
| Completed | Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Re NCT04628234 | Institut de cancérologie Strasbourg Europe | — |
| Completed | CAR-37 T Cells in Hematologic Malignancies NCT04136275 | Marcela V. Maus, M.D.,Ph.D. | Phase 1 |
| Unknown | CAR T-CELL Therapy Educational Video Trial NCT04280133 | Massachusetts General Hospital | N/A |
| Completed | Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels NCT04537715 | Epizyme, Inc. | Phase 1 |
| Completed | Effects of Parenteral Nutrition in HSCT NCT04425642 | St. Petersburg State Pavlov Medical University | N/A |
| Terminated | Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood NCT03717480 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Better Leukemia Diagnostics Through AI (BELUGA) NCT04466059 | Munich Leukemia Laboratory | — |
| Terminated | Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic Malignancy NCT05860075 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Phase 1 |
| Completed | Single Session of 30-Minute Mindful Breathing in Reducing Fatigue NCT05029024 | University Malaysia Sarawak | N/A |
| Completed | Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) NCT03992352 | Center for International Blood and Marrow Transplant Research | — |
| Recruiting | Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity NCT03890614 | Wake Forest University Health Sciences | — |
| Completed | A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP) NCT03823651 | Duke University | N/A |
| Unknown | Nutritional and Physical Exercise Intervention in Older Patients With Malignant Hemopathies NCT04057443 | Maite Antonio, MD, Phd | N/A |
| Completed | Expressive Helping for Stem Cell Transplant Patients NCT03800758 | Northwestern University | Phase 3 |
| Completed | Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy NCT03903185 | Ain Shams University | Phase 1 / Phase 2 |
| Terminated | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies NCT03727009 | Exact Sciences Corporation | — |
| Enrolling By Invitation | Function of Platelets Used for Transfusions NCT05038722 | Sofia Ramström | — |
| Completed | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 NCT03555955 | Jazz Pharmaceuticals | Phase 1 |
| Completed | PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Trans NCT03699631 | Medical College of Wisconsin | Phase 2 |
| Completed | A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients NCT03654404 | Brigham and Women's Hospital | N/A |
| Unknown | Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intub NCT03673631 | Poitiers University Hospital | — |
| Withdrawn | Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hema NCT02718755 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasi NCT03431090 | Nationwide Children's Hospital | Phase 1 / Phase 2 |
| Unknown | CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies NCT03795779 | iCell Gene Therapeutics | EARLY_Phase 1 |
| Unknown | CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies NCT04156256 | iCell Gene Therapeutics | EARLY_Phase 1 |
| Active Not Recruiting | Critical Care Outcomes of Hematologic Oncology Patients NCT03449953 | Mount Sinai Hospital, Canada | — |
| Completed | Distracting Through Procedural Pain and Distress NCT04892160 | Medical College of Wisconsin | N/A |
| Active Not Recruiting | Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo NCT03459170 | Bellicum Pharmaceuticals | Phase 1 |
| Active Not Recruiting | Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy NCT03168815 | Mount Sinai Hospital, Canada | N/A |
| Terminated | Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults NCT03135028 | Gilead Sciences | Phase 1 |
| Completed | Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (H NCT03149055 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Vaccination for Children of H&O and Their Parents NCT03373656 | Children's Cancer Group, China | N/A |
| Completed | The Oronasal Microbiota in Pediatric Oncology Patients NCT02949427 | St. Jude Children's Research Hospital | — |
| Completed | Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory NCT03399149 | University Hospital, Grenoble | — |
| Completed | Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory NCT03133520 | Kursat Gundogan | N/A |
| Active Not Recruiting | Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation NCT02990130 | Garcia, Jose M., MD, PhD | — |
| Completed | Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Recepto NCT02880293 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mu NCT02696408 | Institut de Cancérologie de la Loire | Phase 3 |
| Completed | A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated Wit NCT02711852 | SecuraBio | Phase 2 |
| Completed | Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant NCT02668315 | Maisonneuve-Rosemont Hospital | Phase 1 / Phase 2 |
| Completed | Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT) NCT03419078 | Imperial College Healthcare NHS Trust | — |
| Completed | Non Invasive Optical Imaging of WBC Count NCT02512666 | Massachusetts General Hospital | N/A |
| Completed | A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies NCT02352558 | Sumitomo Pharma America, Inc. | Phase 1 |
| Unknown | Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients NCT02385955 | Seoul National University Hospital | Phase 2 |
| Completed | Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia NCT02669706 | University of Illinois at Chicago | — |
| Completed | Patient-Centered Care for the Older Adult With Hematologic Malignancy NCT02359838 | Dana-Farber Cancer Institute | N/A |
| Completed | Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Ma NCT02583035 | Centre Francois Baclesse | N/A |
| Unknown | Physiotherapy in Hematopoietic Stem Cell Transplantation NCT02193399 | Universidad Católica San Antonio de Murcia | N/A |
| Withdrawn | Reiki as a Complementary Therapy: A Pilot Study NCT02207764 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Unknown | Effect of Smartphone App on Activity NCT02612402 | Rambam Health Care Campus | N/A |
| Recruiting | Prospective Cohort With Hemopathy in Languedoc-Roussillon NCT02134574 | University Hospital, Montpellier | — |
| Terminated | Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies NCT02042924 | Masonic Cancer Center, University of Minnesota | N/A |
| Withdrawn | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies NCT01163201 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Terminated | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain NCT01846429 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Active Not Recruiting | Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers NCT02041416 | City of Hope Medical Center | — |
| Completed | Phase II Maraviroc for GVHD Prevention NCT01785810 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Completed | Evaluation of PET/MRI in Children With Cancer NCT01839747 | Massachusetts General Hospital | N/A |
| Completed | Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous NCT01572181 | Nantes University Hospital | Phase 2 |
| Withdrawn | Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients NCT01554254 | Tarix Pharmaceuticals | Phase 2 |
| Terminated | A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives NCT01532635 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer NCT01324310 | Celgene | Phase 1 |
| Completed | Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer NCT01324323 | Celgene | Phase 1 |
| Terminated | Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow NCT02049424 | Istituto Clinico Humanitas | — |
| Terminated | Influenza Vaccine Post Allogeneic Transplant NCT01215981 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies NCT01341301 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or R NCT00990587 | University Health Network, Toronto | Phase 1 |
| Completed | Outcomes of Critically Ill Patients With Hematologic Malignancies NCT06410066 | Soroka University Medical Center | — |
| Completed | A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignan NCT00840190 | Piramal Enterprises Limited | Phase 1 |
| Completed | Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a NCT00673114 | Joanne Kurtzberg, MD | Phase 1 / Phase 2 |
| Terminated | Voraxaze for Delayed Methotrexate Clearance NCT00424645 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Genetics in the Progression of Nephropathies NCT06416761 | Ospedale San Raffaele | — |
| Unknown | Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes NCT00300001 | Community Cancer Care | — |
| Completed | CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation NCT00333190 | Dana-Farber Cancer Institute | N/A |
| Terminated | Fatigue in Emergency Center Patients NCT00504985 | M.D. Anderson Cancer Center | — |
| Completed | Mindfulness Meditation in Bone Marrow Transplantation NCT00165282 | Emory University | Phase 2 / Phase 3 |
| Completed | Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogenei NCT00476177 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Dis NCT00056966 | Baylor College of Medicine | Phase 1 / Phase 2 |
| Unknown | Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study NCT00156858 | Alberta Health services | N/A |